These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8094603)

  • 1. Catecholamines and the carcinoid syndrome.
    Cross MH
    Anaesthesia; 1993 Jan; 48(1):81-2. PubMed ID: 8094603
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of a malignant bronchial carcinoid affecting the mediastinum and left atrium by radical two stage resection with cardiopulmonary bypass and somatostatin infusion.
    Darby C; Sinclair M; Westaby S
    Br Heart J; 1990 Jan; 63(1):55-7. PubMed ID: 1968753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Somatostatin analogs in the treatment of carcinoid syndrome: a case report and review of literature].
    Junik R; Kamińska A; Kamiński M; Ruprecht Z
    Pol Arch Med Wewn; 2003 Sep; 110(3):997-1001. PubMed ID: 14699693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of somatostatin and salmon calcitonin on carcinoid syndrome. A clinical case].
    Festa V; Garrone C; Vietti Ramus G; Lisa F; Simone P; Scotti M; Cocchis D; Garrone GC
    Minerva Chir; 1989 May; 44(9):1429-33. PubMed ID: 2569698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of somatostatin on bronchial constriction in a patient with carcinoid syndrome.
    Klapdor R
    N Engl J Med; 1980 Aug; 303(8):464. PubMed ID: 6104790
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful symptomatic treatment of malignant carcinoid syndrome with the somatostatin analogue SMS 201-995.
    van Houten AA; Nortier JW; Vendrik CP
    Neth J Med; 1988 Apr; 32(3-4):194-8. PubMed ID: 2896307
    [No Abstract]   [Full Text] [Related]  

  • 7. The carcinoid syndrome.
    Oates JA
    N Engl J Med; 1986 Sep; 315(11):702-4. PubMed ID: 2875390
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid reversal of carcinoid crisis with a somatostatin analogue.
    Kvols LK; Martin JK; Marsh HM; Moertel CG
    N Engl J Med; 1985 Nov; 313(19):1229-30. PubMed ID: 2865675
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of somatostatin infusion in four patients with malignant carcinoid syndrome.
    Quatrini M; Basilisco G; Conte D; Bozzani A; Bardella MT; Bianchi PA
    Am J Gastroenterol; 1983 Mar; 78(3):149-51. PubMed ID: 6187212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoid Flush: role of gastrin and somatostatin.
    N Engl J Med; 1979 Mar; 300(11):624. PubMed ID: 763277
    [No Abstract]   [Full Text] [Related]  

  • 11. An update of lanreotide acetate for treatment of adults with carcinoid syndrome.
    Guadalupe E; Deshpande HA; Stein SM
    Drugs Today (Barc); 2018 Aug; 54(8):457-465. PubMed ID: 30209440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome.
    Ahlman H; Ahlund L; Dahlström A; Nilsson O; Skolnik G; Tisell LE; Tylén U
    Br J Cancer; 1987 Dec; 56(6):840-2. PubMed ID: 2893640
    [No Abstract]   [Full Text] [Related]  

  • 13. Somatostatin, anaesthesia, and the carcinoid syndrome. Peri-operative administration of a somatostatin analogue to suppress carcinoid tumour activity.
    Roy RC; Carter RF; Wright PD
    Anaesthesia; 1987 Jun; 42(6):627-32. PubMed ID: 2887127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin does not prevent serotonin release and flushing during chemoembolization of carcinoid liver metastases.
    Zimmer C; Kienbaum P; Wiesemes R; Peters J
    Anesthesiology; 2003 Apr; 98(4):1007-11. PubMed ID: 12657865
    [No Abstract]   [Full Text] [Related]  

  • 15. Controlling the carcinoid syndrome.
    Hodgson HJ
    BMJ; 1988 Nov; 297(6658):1213-4. PubMed ID: 2905181
    [No Abstract]   [Full Text] [Related]  

  • 16. The management of refractory carcinoid syndrome: challenges and opportunities ahead.
    Cives M; Pellè E; Silvestris F
    J Med Econ; 2018 Mar; 21(3):241-243. PubMed ID: 29039712
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of the administration of somatostatin 14 in the carcinoid syndrome. Clinical and biological study of 2 cases].
    Guillard JF; Galmiche JP; Chayvialle JA; Kremer M; Comoy E; Lerebours E; Charbonnel B; Colin R
    Gastroenterol Clin Biol; 1983 Dec; 7(12):1016-22. PubMed ID: 6141119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.
    Kvols LK; Moertel CG; O'Connell MJ; Schutt AJ; Rubin J; Hahn RG
    N Engl J Med; 1986 Sep; 315(11):663-6. PubMed ID: 2427948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carcinoid syndrome with a course of more than 10 years].
    Baur X; Bortsch A; Autenrieth G; Jacob K; Neudert J; Schneider B; Werdan K
    Internist (Berl); 1988 May; 29(5):347-50. PubMed ID: 2900222
    [No Abstract]   [Full Text] [Related]  

  • 20. Metastatic carcinoid tumors and the carcinoid syndrome. A selective review of chemotherapy and hormonal therapy.
    Kvols LK
    Am J Med; 1986 Dec; 81(6B):49-55. PubMed ID: 2432781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.